9Lun·

Healthcare sector thus also covered and most convinced by J&J🙈🐵

10.09

Johnson&Johnson

Compró 7 a 152,56 €

1067,94 €

6 Comentarios

Tojasoku@Tojasoku

9Lun

For what reason J&J?

•

Ver todas las 3 respuestas adicionales

CrashBurner@Psychedelic_Sunflower

9Lun

Not every sector has to be covered. Pharma is difficult. You either have to be able to assess the pipeline quite well and still move in highly speculative spheres or you have enormously sporty valued companies in front of your nose or, as in the case of Johnson & Johnson, a blue chip portfolio brake with only moderate growth and the constant danger of slipping into some pharmaceutical scandal.

•

Peace@Pinkafeld

9Lun

J&j falls. Abott and Amgen are more stable

••